TP53 and acute myeloid leukemia: Our original hypothesis was to see otherwise, since TP53 mutations occur frequently in MDS, and we reasoned that the tp53M214K mutation may predispose the animals to MDS or AML with an impaired myeloid function that is sensitive to azacitidine.